MORE►
Almaden Genomics
Photo: Michael Samples
Meet the Winners:
D CEO, Dallas Innovates Honor Top Innovators at 2024 Awards
by Dallas Innovates | Staff Report | Jan 25, 2024
At the annual Innovation Awards event, Dallas Innovates and D CEO revealed the winners in 17 categories and recognized all 74 North Texas finalists.
by Lance Murray |
Jun 9, 2023
Ellen Gordon has worked for more than two decades on behalf of pharmaceutical and biotech companies to deliver insights and much-needed solutions. "Her experience supporting the swift development of novel medicines makes her ideal for helping our clients leverage g.nome to accelerate drug discovery," CEO David Gascogine said.
MORE►
by David Seeley |
Jan 30, 2023
Life sciences industry veteran David Gascoigne will lead the new startup, which was launched in October by Catalyze Dallas Holdings.
Almaden's g.nome cloud-native platform offers "an advanced visual drag-and-drop workflow builder" and curated library of toolkits that can speed bioinformatic pipeline building "from what previously has taken months to mere hours," the company says.
MORE►
by Kevin Cummings |
Oct 25, 2022
The Dallas-based venture development firm—which specializes in the commercialization of technology it acquires from Fortune 100 companies—has launched Almaden Genomics, a company with a newly released platform designed to streamline genomic workflows. Formerly part of IBM Research before its acquisition by Catalyze Dallas, Almaden calls its g.nome platform "a revolutionary approach to bioinformatics."
“The possibilities for the healthcare innovation it can power are as vast as they are life-changing," says Mark Kunitomi, Almaden's chief scientific officer.
MORE►
